Palantir Faces a Crucible Week as Global Branching Launch Meets Unforgiving Valuation Math

Palantir's Q1 earnings beat fails to lift stock, trading at 97x forward earnings. Key week ahead with Global Branching launch and Rosenblatt meeting as technical and fundamental signals diverge.

The numbers tell one story, the stock tells another—and Palantir enters a pivotal week with both narratives in open conflict. The data-analytics firm delivered an earnings beat on May 4 that would make most growth companies envious, yet its shares have shed nearly a fifth of their value since January. At €115.38, the stock sits 17% below its 200-day moving average and is bleeding altitude despite a business that continues to accelerate.

Operationally, the quarter was hard to fault. Adjusted earnings per share came in at $0.33, comfortably above the $0.28 consensus, while revenue of $1.63 billion topped expectations by nearly $90 million. It marked the eleventh consecutive quarter of accelerating top-line growth, with revenue surging 85% year-on-year and the Rule of 40—a favored efficiency metric for software companies—hitting a staggering 145%. Management has guided for full-year 2026 revenue of $7.65 billion to $7.66 billion and adjusted free cash flow of $4.2 billion to $4.4 billion.

Yet the market remains unmoved. The reason comes down to a single, unyielding number: the stock trades at 97 times forward earnings. For a company whose commercial bookings are still finding their footing outside the U.S., that multiple has become a lightning rod. HSBC recently slashed its price target by more than a quarter, arguing the premium embedded in the share price can no longer be justified by the trajectory of new business wins. Among the broader analyst community, the consensus is still a "Moderate Buy," with a 12-month average target of roughly $195 and bullish estimates as high as $255—but those projections now feel more aspirational than directional.

The coming days will test whether sentiment can shift. On Monday, Palantir launches "Global Branching," a fresh push to plant its AI platforms more deeply in international markets—a strategic move that comes as rivals Anthropic and OpenAI increasingly chase the large-enterprise accounts Palantir has long owned with its Foundry and AIP systems. The following day, at 1:45 p.m., management sits down with equity analysts from Rosenblatt Securities in a meeting watchers regard as a bellwether for institutional appetite.

Technical traders are watching the same support zone that has contained the stock in recent weeks. A break below current levels could open the door to a re-rating toward $90–$100, while a positive read from the Rosenblatt session might fuel a relief rally back toward $150—provided the floor holds. The 50-day moving average at €124.15 already sits well above the current price, and the relative strength index of 50.8 suggests indecision rather than conviction.

Adding to the pressure is a pronounced divergence in who is buying and who is selling. Institutional names such as SkyOak Wealth, which bulked up its position by 169.5%, and New York Life Investment Management, which added 313,222 shares, have been accumulating. But insider activity tells a darker tale: manager Stephen Andrew Cohen alone shed 327,088 shares. Such sell-side signals rarely inspire confidence in a stock already stretched by expectations.

The annual general meeting on June 3 adds an ESG dimension that management would rather sideline. Shareholder proposals demanding more detailed reporting on human rights risks and military due diligence will go to a vote, with the board recommending against them. The Dutch pension fund ABP has already exited its stake, and several U.S. public pension funds are feeling heat from beneficiaries—a dynamic that could amplify selling pressure if the stock fails to regain its footing.

For now, Palantir finds itself caught between exceptional fundamentals and an unforgiving valuation. The next hard test arrives with the second-quarter report, when investors will demand proof that U.S. growth can scale without the multiple expanding further. Until then, the stock drifts at €115.38, waiting for a catalyst that neither blowout earnings nor a new international initiative have yet delivered.